Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 29, 2020 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics to Report Business Highlights and Second Quarter 2020 Financial Results on August 5, 2020

RAMSEY, N.J. and BOCA RATON, Fla., July 29, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,...
July 06, 2020 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Opens Its Newest ADMA BioCenters Plasma Collection Facility

RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., July 06, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated...
June 23, 2020 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Announces Martha J. Demski Elected to Board of Directors

RAMSEY, N.J. and BOCA RATON, Fla., June 23, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,...
May 27, 2020 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics to Participate in Jefferies Virtual Healthcare Conference

RAMSEY, N.J. and BOCA RATON, Fla., May 27, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to...
May 21, 2020 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Commences Collection of COVID-19 Plasma from Recovered Patients

RAMSEY, N.J. and BOCA RATON, Fla., May 21, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), today announced it has commenced the collection of convalescent plasma through its...
May 07, 2020 07:35 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Provides Corporate Update on Supply Chain Robustness and Recent Accomplishments

RAMSEY, N.J. and BOCA RATON, Fla., May 07, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,...
May 06, 2020 16:05 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress

Achieved First Quarter 2020 Total Revenues of $10.2 Million, a 189% Increase Over First Quarter 2019 Strengthened Balance Sheet Through Successful Completion of Underwritten Public Offering ...
April 29, 2020 07:00 ET | Source: ADMA Biologics, Inc.

ADMA Biologics to Report First Quarter 2020 Financial Results on May 6, 2020

RAMSEY, N.J. and BOCA RATON, Fla., April 29, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,...
March 12, 2020 16:05 ET | Source: ADMA Biologics, Inc.

ADMA Biologics Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Company Progress

Achieved Fourth Quarter 2019 Total Revenues of $12.0 Million, a 197% Increase Over Fourth Quarter 2018 Achieved Full Year 2019 Total Revenues of $29.3 Million, a 73% Increase Over Full Year 2018 ...
March 05, 2020 06:59 ET | Source: ADMA Biologics, Inc.

ADMA Biologics to Report Fourth Quarter and Full Year 2019 Financial Results on March 12, 2020

RAMSEY, N.J. and BOCA RATON, Fla., March 05, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing,...